What is the I3 Study?
|
The IBD Immunology Initiative, or I3 Study, stands at the forefront of research at the esteemed University of Pennsylvania Health System. This groundbreaking study, a collaborative effort between the Division of Gastroenterology and the Institute for Immunology, is dedicated to unraveling the intricate relationship between inflammatory bowel diseases (IBD) and the immune system. Founded by Dr. Meena Bewtra and conducted in partnership with the Penn Institute for Immunology, the I3 Study endeavors to enroll every patient with Crohn's disease, ulcerative colitis, and indeterminate colitis under Penn's care. The primary objective is to establish a comprehensive biobank comprising tissue and blood samples alongside pertinent clinical data. These invaluable resources will fuel a multitude of research endeavors aimed at deciphering the underlying causes of IBD and refining treatment approaches for enhanced patient care. Discover more about the dedicated members of the I3 Team here: |